Anuh Pharma Limited

Anuh Pharma Limited registered a drop in both quarterly revenue and net profit, reflecting challenging industry-wide demand trends. A 'Watch' risk classification and 3 active flags indicate that operating headwinds are beginning to translate into structural pressure.

Anuh Pharma Limited posted steady top-line growth and bottom-line stability, demonstrating resilient execution in its core markets. While the underlying business remains fundamentally sound, the presence of 2 active risk warnings highlights minor operational or working capital inefficiencies to keep on the watch list.